Onconetix (ONCO) EBIT (QoQ) (2021 - 2026)
Onconetix (ONCO) EBIT (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | Onconetix | 1.45 Mn | -4.50 Mn | 4,303.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73.30% |
| Mar 31, 2026 | -698.04% |
| Dec 31, 2025 | 38.08% |
| Sep 30, 2025 | -6.91% |
| Jun 30, 2025 | 84.60% |
| Mar 31, 2025 | 56.87% |
| Dec 31, 2024 | -1,001.56% |
| Sep 30, 2024 | 80.57% |
| Jun 30, 2024 | -22.86% |
| Mar 31, 2024 | 49.74% |
| Dec 31, 2023 | -391.27% |
| Sep 30, 2023 | 32.51% |
| Jun 30, 2023 | -133.46% |
| Mar 31, 2023 | 12.25% |
| Dec 31, 2022 | 16.12% |
| Sep 30, 2022 | 9.90% |
| Jun 30, 2022 | -107.42% |
| Mar 31, 2022 | -72.07% |
| Dec 31, 2021 | -9.80% |
| Sep 30, 2021 | -38.33% |